Table 4.
Baseline | 95% CI | Directly After RFA | 95% CI | P time×randomization | |
---|---|---|---|---|---|
NT‐proBNPint fv (pg/mL) n=29 | 63.9 | 45.1 to 90.5 | 86.9 | 63 to 116.7 | <0.001a |
NT‐proBNPcon fv (pg/mL) n=16 | 97.5 | 61.1 to 155.7 | 102.1 | 65.6 to 158.9 |
NT‐proBNP levels are presented as geometric means with 95% CI. Results from repeated‐measure ANOVA within‐subjects contrast tests are presented and considered statistically significant after Benjamini‐Hochberg correction. ANOVA indicates analysis of variance; CI, confidence interval; con, control group; fv, femoral vein; int, intervention group; n, number of patients available for analysis; NT‐proBNP, N‐terminal pro B‐type natriuretic peptide.
Statistical significant P values after correction for false discovery rate.